Mitomycin C Therapy

Mitomycin C Therapy is a pharmacological intervention involving the topical application of mitomycin C, a chemotherapeutic agent, to selectively inhibit abnormal epithelial cell proliferation in the management of ocular surface neoplasia.

3.5K

Publications

160.3K

Citations

13.9K

Authors

2.7K

Institutions

Publications per year

2017–2026

324

Authors

13.9K

  1. SR
    Sara Rockwell

    Yale University, United States

    24 publications · 1.5K citations

    21

    h-index

  2. AC
    Alan C. Sartorelli

    Yale University, United States

    21 publications · 1.7K citations

    20

    h-index

  3. MH
    Mitsuru Hashida

    Kyoto University, Japan

    19 publications · 723 citations

    15

    h-index

  4. PT
    Peng T. Khaw

    University College London, United Kingdom

    15 publications · 1.5K citations

    14

    h-index

  5. HS
    Hitoshi Sezaki

    Kyoto University, Japan

    18 publications · 663 citations

    13

    h-index

1–5 of 13.9K

Venues

  1. PubMed

    Repository · 436 publications · 17.1K citations

    62

    h-index

  2. Ophthalmology

    85 publications · 9.6K citations

    57

    h-index

  3. Cancer

    123 publications · 8.3K citations

    51

    h-index

  4. Journal of Glaucoma

    130 publications · 5.7K citations

    43

    h-index

  5. British Journal of Ophthalmology

    BJO · 61 publications · 4.4K citations

    42

    h-index

1–5